1BC9 image
Deposition Date 1998-05-06
Release Date 1999-05-11
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1BC9
Keywords:
Title:
CYTOHESIN-1/B2-1 SEC7 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Conformers Calculated:
287
Conformers Submitted:
1
Selection Criteria:
MINIMIZED AVERAGE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CYTOHESIN-1
Gene (Uniprot):CYTH1
Chain IDs:A
Chain Length:200
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1.
Proc.Natl.Acad.Sci.USA 95 7909 7914 (1998)
PMID: 9653114 DOI: 10.1073/pnas.95.14.7909

Abstact

Cytohesin-1 (B2-1) is a guanine nucleotide exchange factor for human ADP ribosylation factor (Arf) GTPases, which are important for vesicular protein trafficking and coatamer assembly in the cell. Cytohesin-1 also has been reported to promote cellular adhesion via binding to the beta2 integrin cytoplasmic domain. The solution structure of the Sec7 domain of cytohesin-1, which is responsible for both the protein's guanine nucleotide exchange factor function and beta2 integrin binding, was determined by NMR spectroscopy. The structure consists of 10 alpha-helices that form a unique tertiary fold. The binding between the Sec7 domain and a soluble, truncated version of human Arf-1 was investigated by examining 1H-15N and 1H-13C chemical shift changes between the native protein and the Sec7/Arf-1 complex. We show that the binding to Arf-1 occurs through a large surface on the C-terminal subdomain that is composed of both hydrophobic and polar residues. Structure-based mutational analysis of the cytohesin-1 Sec7 domain has been used to identify residues important for binding to Arf and for mediating nucleotide exchange. Investigations into the interaction between the Sec7 domain and the beta2 integrin cytoplasmic domain suggest that the two proteins do not interact in the solution phase.

Legend

Protein

Chemical

Disease

Primary Citation of related structures